Sun Pharmaceutical Industries Ltd.

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, further to its intimation dated 17th January 2023 regarding earnings call, Sun Pharmaceutical Industries has informed that the audio recording of the call held today is available on its website. The same can be accessed through below link: https://sunpharma.com/wp-content/uploads/2023/02/Q3-FY22-23-SPIL-Earnings-Call-AudioRecording.mp3.

The above information is a part of company’s filings submitted to BSE.